Gyre Therapeutics Stock Price Patterns
| GYRE Stock | 7.88 0.37 4.93% |
Momentum 53
Impartial
Oversold | Overbought |
Quarterly Earnings Growth 1.662 | EPS Estimate Current Year 0.15 | EPS Estimate Next Year 0.1833 | Wall Street Target Price 18 | EPS Estimate Current Quarter (0.02) |
Using Gyre Therapeutics hype-based prediction, you can estimate the value of Gyre Therapeutics from the perspective of Gyre Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Gyre Therapeutics using Gyre Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Gyre using crowd psychology based on the activity and movement of Gyre Therapeutics' stock price.
Gyre Therapeutics Implied Volatility | 2.78 |
Gyre Therapeutics' implied volatility exposes the market's sentiment of Gyre Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Gyre Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Gyre Therapeutics stock will not fluctuate a lot when Gyre Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Gyre Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Gyre because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Gyre Therapeutics after-hype prediction price | USD 7.89 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Gyre Therapeutics Basic Forecasting Models to cross-verify your projections. Gyre Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Gyre Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Gyre Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Gyre Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Gyre Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Gyre Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Gyre Therapeutics' historical news coverage. Gyre Therapeutics' after-hype downside and upside margins for the prediction period are 4.25 and 11.53, respectively. We have considered Gyre Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Gyre Therapeutics is somewhat reliable at this time. Analysis and calculation of next after-hype price of Gyre Therapeutics is based on 3 months time horizon.
Gyre Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Gyre Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Gyre Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Gyre Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.06 | 3.64 | 0.01 | 0.00 | 8 Events / Month | 8 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
7.88 | 7.89 | 0.13 |
|
Gyre Therapeutics Hype Timeline
Gyre Therapeutics is currently traded for 7.88. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of 0.0. Gyre is projected to increase in value after the next headline, with the price projected to jump to 7.89 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 0.13%, whereas the daily expected return is currently at 0.06%. The volatility of related hype on Gyre Therapeutics is about 45500.0%, with the expected price after the next announcement by competition of 7.88. The company reported the previous year's revenue of 105.76 M. Net Income was 17.9 M with profit before overhead, payroll, taxes, and interest of 102.42 M. Given the investment horizon of 90 days the next projected press release will be in about 8 days. Check out Gyre Therapeutics Basic Forecasting Models to cross-verify your projections.Gyre Therapeutics Related Hype Analysis
Having access to credible news sources related to Gyre Therapeutics' direct competition is more important than ever and may enhance your ability to predict Gyre Therapeutics' future price movements. Getting to know how Gyre Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Gyre Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AVXL | Anavex Life Sciences | (0.15) | 25 per month | 0.00 | (0.10) | 8.16 | (10.97) | 41.40 | |
| ERAS | Erasca Inc | (0.56) | 9 per month | 2.50 | 0.35 | 15.04 | (4.76) | 50.26 | |
| CTMX | CytomX Therapeutics | 0.07 | 3 per month | 4.40 | 0.11 | 8.21 | (8.51) | 34.41 | |
| MBX | MBX Biosciences Common | 1.09 | 9 per month | 3.90 | 0.17 | 14.40 | (7.47) | 29.11 | |
| MLTX | MoonLake Immunotherapeutics | (1.22) | 9 per month | 3.65 | 0.12 | 8.68 | (6.36) | 35.46 | |
| ATXS | Astria Therapeutics | 0.04 | 5 per month | 1.00 | (0.01) | 2.11 | (1.67) | 6.54 | |
| KROS | Keros Therapeutics | 0.54 | 8 per month | 2.36 | 0.06 | 5.33 | (3.36) | 20.93 | |
| MGTX | MeiraGTx Holdings PLC | 0.16 | 7 per month | 0.00 | (0.09) | 5.08 | (5.54) | 16.37 | |
| IOVA | Iovance Biotherapeutics | 0.12 | 7 per month | 4.13 | 0.08 | 11.81 | (7.58) | 37.34 | |
| AVBP | ArriVent BioPharma Common | (0.17) | 4 per month | 2.91 | 0.08 | 6.71 | (4.81) | 18.12 |
Gyre Therapeutics Additional Predictive Modules
Most predictive techniques to examine Gyre price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Gyre using various technical indicators. When you analyze Gyre charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Gyre Therapeutics Predictive Indicators
The successful prediction of Gyre Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Gyre Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Gyre Therapeutics based on analysis of Gyre Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Gyre Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Gyre Therapeutics's related companies. | 2023 | 2025 (projected) | Dividend Yield | 0.15 | 0.17 | Price To Sales Ratio | 13.8 | 8.76 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Complementary Tools for Gyre Stock analysis
When running Gyre Therapeutics' price analysis, check to measure Gyre Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gyre Therapeutics is operating at the current time. Most of Gyre Therapeutics' value examination focuses on studying past and present price action to predict the probability of Gyre Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gyre Therapeutics' price. Additionally, you may evaluate how the addition of Gyre Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Transaction History View history of all your transactions and understand their impact on performance |